Oral calcium suppresses biochemical markers of bone resorption in normal men

Am J Clin Nutr. 1994 Dec;60(6):965-8. doi: 10.1093/ajcn/60.6.965.

Abstract

Calcium supplementation decreases bone resorption and retards bone loss in women. There is little information about the effects of calcium supplementation in men. The effects of a 1-g oral calcium load at 0900 on bone-related biochemical variables were evaluated in 13 normal men (aged 51-70 y). Calcium administration was associated with increases in plasma ionized calcium (P < 0.001) and urinary calcium (P < 0.001), and a decrease in plasma parathyroid hormone (P < 0.001). There was a nonsignificant trend (r = -0.47, P = 0.11) for the decrease in plasma parathyroid hormone to be related to radiocalcium absorption. After the calcium load there were decreases in the urinary hydroxyproline-creatinine ratio from 11 +/- 1.1 to 7.9 +/- 0.6 (P < 0.01), the urinary deoxypyridinoline-creatinine ratio from 14.0 +/- 1.8 to 10.1 +/- 0.9 (P < 0.05), and the urinary pyridinoline-creatinine ratio from 52 +/- 5 to 40 +/- 3 (P < 0.01) between baseline and 6 h. There was no change in plasma osteocalcin. These observations indicate that a 1-g calcium load suppresses biochemical markers of bone resorption for > or = 6 h in normal men and support the concept that calcium supplementation may be useful in the prevention of bone loss in men.

MeSH terms

  • Absorption
  • Adult
  • Amino Acids / urine
  • Biomarkers*
  • Bone Resorption*
  • Calcium / administration & dosage
  • Calcium / pharmacology*
  • Calcium / urine
  • Calcium Radioisotopes
  • Creatinine / urine
  • Humans
  • Hydroxyproline / urine
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood

Substances

  • Amino Acids
  • Biomarkers
  • Calcium Radioisotopes
  • Parathyroid Hormone
  • pyridinoline
  • deoxypyridinoline
  • Creatinine
  • Hydroxyproline
  • Calcium